Form 4: IN8BIO, INC.: Chief Operating Officer Kate Rochlin Reports Stock Option Grant

Kate Rochlin, Chief Operating Officer of IN8BIO, INC., reports the acquisition of stock options on February 5, 2025.

Summary

• On February 5, 2025, Kate Rochlin, the Chief Operating Officer of IN8BIO, INC., was granted employee stock options.
• The options allow her to purchase 338,950 shares of common stock at an exercise price of $0.29 per share.
• The options vest over time, with 25% vesting on February 5, 2026, and the remaining shares vesting in 36 equal monthly installments thereafter, contingent upon continued service.
• Following the transaction, Rochlin directly owns 338,950 derivative securities.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a stock option grant. It's a standard practice, so neither particularly positive nor negative.

Positives

• The grant of stock options to the Chief Operating Officer aligns her interests with those of the shareholders, incentivizing her to contribute to the company's success.

Future Outlook

The vesting schedule of the options is tied to continued service, suggesting an expectation of Rochlin's continued involvement with the company.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• The vesting schedule of 25% after one year followed by monthly installments is a typical arrangement to incentivize long-term commitment.
• Comparable companies in the biotechnology sector, such as Juno Therapeutics (acquired by Celgene) and Kite Pharma (acquired by Gilead), have utilized similar stock option plans for their executive teams.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the COO to drive company growth.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates